Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C H Carbonylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel cobalt-catalyzed C-H activation method for tetrahydro-beta-carbolinones. High yields, scalable process for API intermediates replacing palladium.
Patent CN112321593B details a novel cobalt-catalyzed carbonylation route for indolo[1,2-a]quinazolin-6(5H)-ones, offering a cost-effective alternative to palladium methods for pharmaceutical intermediates.
Patent CN115260188A details a novel cobalt-catalyzed carbonylation route for tetrahydro-beta-carbolinones, offering a cost-effective alternative to palladium methods for API intermediates.
Novel cobalt catalyzed carbonylation method offers cost effective scalable production for pharmaceutical intermediates ensuring high purity and supply continuity
Novel Pd-catalyzed multi-component route eliminates toxic CO gas, offering cost-effective production of high-purity pharmaceutical intermediates with superior scalability.
Novel patent CN115403505B enables efficient thioester synthesis using sulfonyl chloride. Delivers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN115260188B reveals cobalt-catalyzed synthesis for high-purity pharmaceutical intermediates. Achieve cost reduction and scalable manufacturing efficiency.
Patent CN115260188B reveals cobalt catalyzed synthesis offering cost reduction and scalable manufacturing for high purity pharmaceutical intermediates with simplified purification processes.
Novel cobalt-catalyzed synthesis offers cost reduction and scalability for high-purity pharmaceutical intermediates manufacturing supply chain reliability.
Novel palladium-catalyzed method reduces costs and improves supply chain reliability for high-purity indole ketone thioester manufacturing processes globally.
Novel palladium-catalyzed route for indolone thioesters. Enhances supply chain reliability and reduces manufacturing costs for high-purity pharmaceutical intermediates.
Patent CN115677674B reveals a novel palladium-catalyzed route enabling cost reduction in pharmaceutical intermediates manufacturing with high purity.
Patent CN115260188B details cobalt-catalyzed carbonylation for tetrahydro-beta-carboline ketones, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115260188A details a novel cobalt-catalyzed carbonylation for tetrahydro-beta-carbolinones, offering a cost-effective, scalable alternative to palladium methods for API intermediates.
Novel Pd-catalyzed thiocarbonylation for (iso)chroman thioesters. Avoids thiols, uses sulfonyl chlorides. Cost-effective pharma intermediate manufacturing.
Novel palladium-catalyzed cascade reaction for heterocyclic compounds. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115403505B reveals palladium-catalyzed route using sulfonyl chloride. Offers cost reduction in pharmaceutical intermediates manufacturing and high-purity output.
Novel nickel-catalyzed synthesis reduces costs and improves supply chain reliability for high-purity alpha beta-unsaturated thioester pharmaceutical intermediates manufacturing.
Novel cobalt-catalyzed C-H carbonylation for indolo[1,2-a]quinazolin-6(5H)-ones. Cost-effective, scalable route for pharmaceutical intermediates.
Patent CN115260188A details a novel cobalt-catalyzed C-H activation method for tetrahydro-beta-carbolinones, offering cost reduction in API manufacturing and scalable production.